EDGAR Filing Documents for 0001650664-24-000105

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001650664-24-000105

Filing Date

2024-09-06

Accepted

2024-09-06 16:20:37

Documents

Period of Report

2024-09-04

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wk-form4_1725654028.html	4
1	FORM 4	wk-form4_1725654028.xml	4	4096
	Complete submission text file	0001650664-24-000105.txt		5520

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141

Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000

Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O EDITAS MEDICINE, INC. 1 MAIN STREET CAMBRIDGE MA 02142

Business Address

Mei Baisong (Reporting) CIK: 0001938499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 241284777